Ochoa Gómez F J, Carpintero Escudero J M, Ramalle-Gómara E, Lisa Catón V, Marco Aguilar P
Unidad de Cuidados Intensivos, Complejo Hospitalario San Millán-San Pedro del Insalud, Logroño, La Rioja.
An Med Interna. 1998 Feb;15(2):80-2.
Only one third of patients who have suffered a myocardial infarction can benefit from thrombolytic treatment in the daily clinic practice. The aim of this study is to know the percentage of patients who were treated in a General Hospital and the main exclusion causes to receive thrombolytic treatment.
A descriptive study in patients with infarction who were admitted to the Critical Care Unit of a 550 beds Hospital between September-95 and August-96.
188 patients were admitted with suspicion of myocardial infarction. The 50.53% of them received thrombolytic treatment. The main exclusion causes to receive this treatment were: delay of the patient (18.10%), normal ECG or descended ST (16.50%), contraindications (8%), patient's refusal to receive treatment (0.53%) an uncertain indication of therapy (6.40%).
A high percentage of patients received thrombolytic therapy, maybe because these drugs can be used until 12 hours the infarction and they haven't limit of age.
在日常临床实践中，只有三分之一的心肌梗死患者能从溶栓治疗中获益。本研究的目的是了解在综合医院接受治疗的患者比例以及接受溶栓治疗的主要排除原因。
对1995年9月至1996年8月期间入住一家拥有550张床位医院重症监护病房的梗死患者进行描述性研究。
188例患者因疑似心肌梗死入院。其中50.53%的患者接受了溶栓治疗。接受该治疗的主要排除原因有：患者延误（18.10%）、心电图正常或ST段下降（16.50%）、禁忌症（8%）、患者拒绝接受治疗（0.53%）、治疗指征不明确（6.40%）。
很高比例的患者接受了溶栓治疗，可能是因为这些药物可在梗死发生后12小时内使用且没有年龄限制。
